Putnam Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Putnam Investments’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-51,708	Closed	-$416K	–	1244
2023 Q3	$416K	Buy	+51,708	New	+$430K	﹤0.01%	949
2016 Q3	–	Sell	-75,000	Closed	-$381K	–	1365
2016 Q2	$381K	Hold	75,000	–	–	﹤0.01%	1235
2016 Q1	$1.61M	Hold	75,000	–	–	﹤0.01%	1001
2015 Q4	$2.29M	Hold	75,000	–	–	0.01%	940
2015 Q3	$2.5M	Hold	75,000	–	–	0.01%	926
2015 Q2	$3.48M	Hold	75,000	–	–	0.01%	869
2015 Q1	$2.7M	Hold	75,000	–	–	0.01%	957
2014 Q4	$3.16M	Hold	75,000	–	–	0.01%	896
2014 Q3	$1.94M	Buy	+75,000	New	+$2.32M	﹤0.01%	1030

Other funds holding MRNS

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Putnam Investments's MRNS Position: Q4 2023 in Review

Putnam Investments sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2023, closing a stake of 51,708 shares — an estimated $416K sold.

Putnam Investments first reported a position in MRNS in Q3 2014 and held it in 9 quarters. The position peaked at $3.48M in Q2 2015. 105 funds tracked by Wall St. Rank hold MRNS as of Q4 2023.

Putnam Investments reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Putnam Investments sold 51,708 Marinus Pharmaceuticals, Inc shares in Q4 2023, an estimated $416K.
Putnam Investments first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 9 quarters.
Putnam Investments's Marinus Pharmaceuticals, Inc position peaked at $3.48M in Q2 2015.
105 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.